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Studies have documented that the pathogenesis of autoimmune diabetes is influenced by the intake of gluten. Aims. To investigate
the importance of gluten exposure during pregnancy and the subsequent development of autoimmune diabetes in offspring.
Methods. Nonobese diabetic mice were divided into 7 groups to receive combinations of gluten-free and standard diet before,
during, or after pregnancy. Diabetes incidence in offspring was followed in each group (𝑛 = 16–27) for 310 days. Insulitis score and
intestinal expression of T-cell transcription factors (RT-QPCR) were evaluated in animals from the different diet groups. Results.
If mothers were fed a gluten-free diet only during pregnancy, the development of autoimmune diabetes in offspring was almost
completely prevented with an incidence reduction from 62.5% in gluten-consuming mice to 8.3% (𝑝 < 0.0001) in the gluten-free
group.The islets of Langerhans were less infiltrated (𝑝 < 0.001) and the intestinal expression of ROR𝛾t (Th17) (𝑝 < 0.0001) reduced
in mice whose mothers were Gluten-free during pregnancy. Conclusion. A gluten-free diet exclusively during pregnancy efficiently
prevents autoimmune diabetes development in offspring and reduces insulitis and intestinal expression of ROR𝛾t (Th17).
1. Introduction
Gluten exposure is an important factor in the development
of type 1 diabetes (T1D) [1]. Both in nonobese diabetic
(NOD) mice and in Biobreeding- (BB-) rats a gluten-free
(GF) [2, 3] or hydrolyzed [4] diet lowers the incidence of the
diseasemarkedly. In humans, a GF, low carbohydrate diet was
recently reported to induce remission in a newly diagnosed
T1D patient [5], and improved insulin secretion has been
observed after 6 months of GF diet [6]. The appearance
of beta cell autoimmunity may be related to the age at
introduction of cereals into the infant diet [7, 8]. Further, a
high dietary content of monosaccharides increases the risk of
developing T1D [9, 10].
The mechanism by which gliadin influences disease
development is not known. It is likely that gut immunity is
involved since we [11] and others [12, 13] have reported that
gluten intake confers a proinflammatory cytokine profile in
multiple regulatory T cell populations, including 𝛾𝛿 T cells,
in mucosal lymphoid tissues. It is likely that these changes are
facilitated by or even dependent on gluten peptides being able
to transverse the epithelium,whichwe recently demonstrated
in NOD and BALB/c mice (unpublished) and which was
previously reported in T1D patients [14].
It is also possible that a direct effect of gluten peptides
on the beta cells can influence disease development. We
have shown that a 33-mer gliadin peptide can directly close
the K channel and induce insulin secretion [15]. Although
it is not clear at the present time whether gliadin interacts
directly with the K channel or the signal is relayed through
other receptors, such as TLR4, this cellular activation might
increase the risk of disease development through beta cell
stress [16].
Previous experiments with GF diet in animal models
of autoimmune diabetes [2, 3, 17] were all carried out in
animals exposed to GF diet both during pregnancy and
during the neonatal period. However, the potential of gluten
to affect the diabetogenic process seems to be dependent
Hindawi Publishing Corporation
Journal of Diabetes Research
Volume 2016, Article ID 3047574, 7 pages
http://dx.doi.org/10.1155/2016/3047574
2 Journal of Diabetes Research
0 4 83
(wks)
62.5%
66.7%
56.3%
30.0%
36.4%
8.3%
31.6%
I
II
III
IV
V
VI
VII
Pregnancy Weaning
Figure 1: Experimental design of the seven groups of animals
(breeding pairs and subsequent offspring). Administration of GF
diet is shown in red and that of normal, gluten-containing chow is
shown in blue. In groups IV–VI, the GF diet was initiated at the time
of mating.
on the time of gluten introduction, both in animals [12, 13]
and in humans [7, 8]. It is therefore not known if there is a
critical period, during which the effect of a GF diet is most
efficient, or if both time slots are equally important. This
was investigated in this study, which showed that GF diet,
exclusively during pregnancy, far exceeds the efficiency of
other treatment periods.
2. Methods
2.1. Animals. Breeding pairs of NOD mice were purchased
from Taconic US, Taconic Europe A/S, Ry, Denmark, arrived
at 4 weeks of age, andwere divided into 7 groups receivingGF
diet at different time points (Figure 1). Mating was initiated
when animals were 7 weeks old. Pregnancy (21 days) and
weaning period (21 days) were carefully recorded to allow
precise timing for diet changes. After weaning, the incidence
of type 1 diabetes wasmonitored among female offspring.The
groupswere as follows: Group I, breeding pairs and offsprings
received STD diet throughout the study; Group II, breeding
pairs were on a STD diet and offspring received GF diet from
4 weeks of age; Group III, breeding pairs were on a STD diet
and offspring received GF diet from 8weeks of age; Group IV,
breeding pairs and offsprings received GF diet from mating
time, during pregnancy, and throughout the study; Group V,
breeding pairs received GF diet frommating time and during
pregnancy and weaning and offspring was then put on a STD
diet; Group VI, breeding pairs were put on a GF diet from
mating time and during pregnancy and after delivery on a
STD diet and offsprings continued the STD diet; and Group
VII, breeding pairs were on a GF diet from arrival, mating,
and pregnancy and after delivery on a STDdiet and offsprings
Table 1: Composition of diets.
STD GF
Crude protein (g/kg) 227.8 228.2
Meat protein (g/kg) 84.0 153.0
Wheat protein (g/kg) 68.4 0
Gliadin 7.2 g/kg <0.075mg/kg
Soybean protein (g/kg) 65.3 65.3
Milk protein (g/kg) 10.0 10.0
Saccharose (g/kg) 58.0 486.7
Monosaccharide (g/kg) 6.3 6.3
Disaccharide (g/kg) 104.5 506.3
Polysaccharide (g/kg) 285.8 9.4
Crude fat (g/kg) 83.5 82.7
Crude fibre (g/kg) 28.7 28.7
Crude ash (g/kg) 71.3 61.6
Glutamic acid (g/kg) 38.6 28.1
Moisture (g/kg) 91.6 44.3
Metabolizable energy (Kcal/kg) 3640.3 3843.6
continued the STD diet. Diabetes incidence was followed in
each group of offsprings (n = 16–27) for 310 days.
The mice were kept in a Specific Pathogen-Free (SPF)
animal facility (temperature 22 ± 2 degrees, 12 h light cycle,
air change 16 times per hour, and humidity 55±10%)with free
access to water and food.The cages had nestingmaterials and
a cardboard shelter.The animal experiments were carried out
with approval from The Animal Experiments Inspectorate
(2012-15-2934-00086), and experiments were regulated by
Directive 2010/63/EU on the protection of animals used for
scientific purposes.
2.2. Diets. The animals received either the STD, nonpurified
Altromin diet or a GF, modified Altromin diet (Altromin,
Lage, Germany). Both experimental diets were nutrition-
ally adequate with a similar level of protein, amino acids,
minerals, vitamins, and trace element, and only the protein
source differed between the diets. The exact composition of
the STD and the GF diet is given in Table 1. The protein
contents of the GF diet and the STD diet were similar (22.7%
versus 22.9%). Proteins in the STD diet were derived from
wheat (25%), maize, and soya, whereas the GF diet protein
source was meat and soya proteins. The two diets also had
the same content of amino acids, minerals, vitamins, and
trace elements. The contents of gliadin in the STD and
GF diet (Table 1) were measured by the GlutenTox ELISA
Competitive assay (Biomedal Diagnostics, Sevilla, Spain).
The weight of the mice was monitored, and both groups of
animals displayed similar weight distribution.
2.3. Diabetes Incidence. NOD females were inspected daily
for diabetes and from 84 days of age screened weekly for
glycemia using FreeStyle Lite (Abbott) glucose monitoring.
Diabetes diagnosis was based on two positive glycemia
readings >12mM with an interval of two days. The date of
the first positive glycemia reading was used as diabetes onset
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date. Mice were killed at diabetes onset or at the age of 310
days. If animals died from other causes, this was noted, and
values were excluded when calculating incidence.
2.4. Insulitis Score. Five mice in each group were used to
evaluate insulitis score. Pancreas was removed, fixed in
4% paraformaldehyde overnight, embedded in paraffin, and
sectioned in 4 𝜇m sections that were subsequently stained
in hematoxylin and eosin. The sections were evaluated ran-
domly and blinded by microscopy. Each section was scored 0
through 4 according to the following scale: (0) intact islets,
(1) peri-insulitis, (2) moderate insulitis (<50% of the islets
infiltrated), (3) severe insulitis (>50% of the islets infiltrated),
and (4) islet destroyed.
2.5. RNA Isolation. Jejunal samples were stored in RNAlater
(Sigma, USA) and RNA was isolated using the TRIzol pro-
cedure (Invitrogen, USA). Tissues were homogenised with
a Polytron PT10-35 (Kinematica, Switzerland) at medium
speed for 10 s on ice. RNA was dissolved in sterile water and
precipitated with sodium acetate. Quality and concentration
were measured on a NanoDrop 1000 Spectrophotometer
(Thermo Scientific, USA).
2.6. Real-Time Quantitative Polymerase Chain Reaction (RT-
qPCR). 500 ng of RNA was reverse transcribed into cDNA
using the qScript cDNA SuperMix (Quanta Biosciences,
USA) according to the manufacturer’s protocol. cDNA was
diluted 1 : 1 with sterile water.
Quantification of specific mRNA was carried out with
FastStart SYBR I qPCR mixture (Roche Diagnostics GmbH,
Germany). The cell type is indicated in parenthesis that is
characterized by the specific transcript. Primers, designed for
an annealing temperature of 60∘C using Primer3 software
[18] and produced by TAG Copenhagen (Denmark), were
as follows: Cyclophilin A (GTG GTC TTT GGG AAG GTG
AA and TTA CAG GAC ATT GCG AGC AG), Foxp3 (Treg)
(CAA TGT GGC CAG TCT GGA AT and ATG ATC TGC
TTG GCA GTG CT), T-bet (TH1) (CAT GGA GAA CGG
AGA ATG GA and CCG CAG TCA CCT GAG TCT TC),
Gata3 (TH2) (GGAAACTCCGTCAGGGCTAC andGTG
GAT GGA CGT CTT GGA GA), ROR𝛾t (TH17) (CCG CTG
AGA GGG CTT CAC and TGC AGG AGT AGG CCA CAT
TAC A), gamma-delta T cells (intraepithelial lymphocytes)
(CAC CAA GCT AGA GGG GTC CT and GTC CGG GCC
TTC ATA AAC AT), and NKp46 (NK cells) (ATG ACA
CAC CCA ACC TCT GG and TCA CTG GGA AAA GAC
CAT GC). Quantification was performed on a LightCycler
II (Roche, USA) with initial denaturation at 95∘C for 10min
followed by 45 cycles of denaturation at 95∘C for 10 s, anneal-
ing at primer-specific temperatures, that is, 56–60∘C for 5 s
and extension at 72∘C for 15 s. Sequence-verified (GATC,
Germany) PCR products were used to construct standard
curves for each target, and these were applied to calculate
the absolute expression levels by LightCycler Software version
4.05. Specificity was checked by melting curve analysis and
unspecific reactions were treated as outliers. Results were
normalized relatively to the housekeeping gene cyclophilinA.
2.7. Statistical Analysis. The cumulative diabetes incidence
was assessed using Kaplan-Meier estimation, and log-rank
test was used to calculate significant differences between
the groups. RT-qPCR data from groups with small sample
size were log-transformed and the statistical significance of
differences was analysed by one-way ANOVA followed by
Bonferroni’s multiple comparison test. RT-qPCR data from
groups with sufficient sample size were analysed by Student’s
unpaired 𝑡-test. Data are presented as mean ± standard
deviation (SD). Statistical significance (𝑝 < 0.05 or 𝑝 < 0.01)
is indicated by one or two asterisks in the figures, respectively.
GraphPad Prism version 5.00 (GraphPad software, Califor-
nia) was used for the calculations.
3. Results
In previous experiments with GF diet in mice, the animals
were fed the special diet during pregnancy as well as postna-
tally. To clarify which period would account for the resulting
beneficial effect on type 1 diabetes development, we gave a GF
diet to NODmice at various time points as shown in Figure 1,
ranging from standard diet throughout their life (Group I) to
GF diet exclusively in utero (Group VI).
3.1. Offsprings Not Exposed to Gluten in Utero Have the
Lowest Diabetes Incidence. The diabetes incidence is shown
in Figure 2. The incidence in the control group was 62.5%
but as low as 8.3% in the group of animals that were not
exposed to gluten in utero (𝑝 < 0.0001). Among animals GF
in utero, the incidence was 30% if the mice received a GF diet
after birth (Group IV), 36.4% if the diet was switched to STD
diet 3 weeks after birth (Group V), and 31.6% if the mothers
received a GF diet before and during but not after pregnancy
(GroupVII). On the other hand, if themice received STDdiet
after birth and if GF diet was introduced when offspring was
4 or 8 weeks old (Groups II and III, resp.), the incidence was
66.7% and 56.3%, respectively.
3.2. Offspring of Mothers on GF Diet during Pregnancy
Had Less Islet Infiltration. To possibly correlate pancreatic,
immunological activity with the disease incidence, we scored
the islet infiltration in pancreatic sections from mice from
the various experimental groups (Figure 3). In general, there
was less infiltration in sections from mice that had not been
exposed to gluten in fetal life than from pubs of mice that
received a gluten-containing diet, but not a direct correlation.
For instance, there is less infiltration in sections from Group
II compared to Group I, although the incidence is almost
similar. Also, the infiltration in Group VII seems less, but this
is not reflected in the incidence. Over all, though, there is less
infiltration in sections from mice not exposed to gluten in
utero (Groups IV–VII) compared to mice exposed to gluten
in utero (Groups I–III) (𝑝 < 0.001).
3.3. GF Diet in Utero Reduces the Level of Intestinal ROR𝛾t
mRNA Expression in Offsprings. Since lymphocytes homing
to the local, pancreatic lymph nodes also home to the
intestine, changes in the immunological profile in the gut
4 Journal of Diabetes Research
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Figure 3: (a) Insulitis score in the experimental groups. (b) Microphotograph of normal islet (left) and severely infiltrated islet (right,
corresponding to stage 3) in each group. Groups IV–VII differ from Groups I–III (𝑝 < 0.001).
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are likely to reflect changes in the pancreas. We performed
qRT-PCR on a number of different T cell transcription
factors on intestinal tissues fromoffspring (13-week-oldNOD
mice) from each of the different diet groups. Expression
levels in intestinal tissue were markedly unaltered by diet
(Figure 4). We did not find any diet-induced changes in
the expression of Foxp3, T-bet, GATA-3, 𝛾𝛿, or NKp46.
However, the expression of ROR𝛾t, a nuclear transcription
factor characteristic for Th17 cells, was significantly changed
by diet. When comparing mice exposed to gluten in utero
(Groups I–III) with mice not exposed to gluten in utero
(Groups IV–VII) we found a significant reduced expression
level (𝑝 < 0.0001) of ROR𝛾t in the GF groups. Also, this
was the only factor that consistently had lower expression
6 Journal of Diabetes Research
for these animals compared to animals that had experienced
gluten in utero. Other markers as T-bet and Gata3 (markers
for Th1 andTh2 differentiation) and 𝛾𝛿 T cells, characteristic
for intraepidermal lymphocytes, did not differ. Also, markers
for regulatory T cells (FoxP3) and NK cells (NKp46) did not
differ between the diets.
4. Discussion
We found a remarkably low incidence of diabetes in NOD
mouse offspring that was GF in utero. Although we expected
that the incidence of autoimmune diabetes in the offspring
of NOD mice, receiving GF diet during pregnancy, would be
lower than in control animals, immediate exposure to gliadin
postnatally resulted in a much lower disease frequency than
in offspring of mice which stayed on a GF diet.
The importance of a GF diet in utero has also been found
in a recent study [17]. Althoughwe also observed this effect in
our study (any experimental group, whosemothers received a
GF diet during pregnancy, had a lower disease frequency than
any experimental group whose mothers received gluten in
utero), the postnatal exposure to gluten in the current study
further reduced the disease incidence markedly. Thus, while
there is a beneficial effect of the absence of gluten during
pregnancy, there seems to be an additionally beneficial effect
of exposure to gluten postnatally which largely is reflected
in the islet infiltration. However, in some cases (i.e., Group
V and Group VI), only minor difference is seen in the islet
infiltration, suggesting functional differences between the
infiltrates [19].
The mechanisms underlying these observations are not
fully elucidated, but results from other investigations suggest
some explanations. Thus, in mice that are fed a gluten-
containing diet, gluten creates a proinflammatory cytokine
profile in the pancreatic lymph nodes and leads to decreased
proportions of various T regulatory subsets, including 𝛾𝛿
T cells, within the mucosal lymphoid compartment [20,
21]. As we recently demonstrated that gluten fragments are
readily absorbed from the intestinal tract following oral
administration in mice [unpublished observation], gliadin
stimulation could also take place in pancreas as well as in
the intestinal mucosa. At present, it is not clear how this
translates into an increased islet-directed T cell activity, but
antigen spreading and an increased level of cytokines in the
lymph nodes could probably help activate several immune
cells unspecifically.
This mechanism could explain why a GF diet during
pregnancy is beneficial, since the absence of gluten at this
time would leave the mice maximally reactive to gluten
antigens. Postnatal gluten exposure would then result in an
increased immune respons, and gluten would then not reach
the islets of Langerhans. Another explanation could be that
the postnatal gluten introduction could result in a beneficial
immune response in the intestinal mucosa towards gluten,
perhaps mediated by the formation of a regulatory immune
response to gluten peptides. If gluten is only introduced
after weaning (Group V) the immune system is probably too
developed and already targeted towards the pancreatic islets,
resulting in a higher disease incidence.
An interesting observation is that the very low disease
incidence (Group VI) is not found if the mothers also receive
a GF diet before the pregnancy (Group VII). A working
hypothesis for explaining this could be that the absence of
gluten would decrease the level of insulin in the mother
[unpublished observation], which would increase the insulin
sensitivity and result in lower blood glucose values. This
would delay islet maturation in the fetuses and thus not
expose beta cell antigens before the thymus barrier closes.
In agreement with this, neonatal glucose injections reduce
the incidence of the disease, probably by increasing beta cell
antigen expression and tolerance induction [22]. A human
analogue to this mechanism is children of diabetic mothers
that experience high glucose values in utero and develop
diabetes at a lower incidence compared to children of diabetic
fathers [23].
The direct translation of the results into the human
disease would be to recommend the exclusion of gluten
during pregnancy, but the question is if it could affect the
incidence of celiac disease. Earlier, epidemiological investiga-
tions have demonstrated that the timing and mode of gluten
introduction are critical for the incidence of celiac disease
later in life, but recent results from prospective, randomized
trials in genetically predisposed individuals showed that there
was no such effect when gluten was introduced at 4, 6, or
12 months of age or whether or not children were breastfed.
The same was found in children that were not genetically
predisposed [24]. This suggests that the risk of developing
celiac disease is unrelated to gliadin exposure. Therefore it
could be interesting to test the above recommendation in a
prospective human trial.
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